Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 50012059
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553728(CHEMBL4757321)
Affinity DataIC50: 30nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553729(CHEMBL4796786)
Affinity DataIC50: 53nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553730(CHEMBL4779758)
Affinity DataIC50: 70nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553719(CHEMBL4744579)
Affinity DataIC50: 205nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553720(CHEMBL4754194)
Affinity DataIC50: 282nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553691(CHEMBL4743946)
Affinity DataIC50: 645nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553723(CHEMBL4783246)
Affinity DataIC50: 720nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553733(CHEMBL4777329)
Affinity DataIC50: 791nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553722(CHEMBL4742852)
Affinity DataIC50: 877nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553724(CHEMBL4782443)
Affinity DataIC50: 996nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553690(CHEMBL4746343)
Affinity DataIC50: 1.02E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553721(CHEMBL4761633)
Affinity DataIC50: 1.19E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553727(CHEMBL4751664)
Affinity DataIC50: 1.20E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553693(CHEMBL1164334)
Affinity DataIC50: 1.20E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553712(CHEMBL4746284)
Affinity DataIC50: 1.38E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553726(CHEMBL4765205)
Affinity DataIC50: 1.47E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553703(CHEMBL1446966)
Affinity DataIC50: 1.50E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553711(CHEMBL4748747)
Affinity DataIC50: 1.54E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553717(CHEMBL4741591)
Affinity DataIC50: 1.76E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553697(CHEMBL4796514)
Affinity DataIC50: 1.81E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553714(CHEMBL4791269)
Affinity DataIC50: 2.29E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553713(CHEMBL4780053)
Affinity DataIC50: 2.49E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553700(CHEMBL1407741)
Affinity DataIC50: 2.69E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553715(CHEMBL1944807)
Affinity DataIC50: 2.88E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553725(CHEMBL4751193)
Affinity DataIC50: 3.08E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553689(CHEMBL4794396)
Affinity DataIC50: 3.18E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553705(CHEMBL4743608)
Affinity DataIC50: 4.88E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553698(CHEMBL4784580)
Affinity DataIC50: 6.01E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553708(CHEMBL1535921)
Affinity DataIC50: 6.08E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553699(CHEMBL4751161)
Affinity DataIC50: 6.77E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553709(CHEMBL159895)
Affinity DataIC50: 8.48E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553694(CHEMBL4792470)
Affinity DataIC50: 9.32E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553701(CHEMBL4777944)
Affinity DataIC50: 9.98E+3nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553732(CHEMBL1164403)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553702(CHEMBL1947235)
Affinity DataIC50: 1.07E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553707(CHEMBL1947233)
Affinity DataIC50: 1.28E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553692(CHEMBL4780944)
Affinity DataIC50: 1.69E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553704(CHEMBL4796954)
Affinity DataIC50: 3.15E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553695(CHEMBL4791714)
Affinity DataIC50: 3.16E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553706(CHEMBL4790786)
Affinity DataIC50: 3.16E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553710(CHEMBL4762619)
Affinity DataIC50: 3.16E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553696(CHEMBL4786709)
Affinity DataIC50: 3.16E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553718(CHEMBL4754335)
Affinity DataIC50: 3.16E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553716(CHEMBL1944797)
Affinity DataIC50: 3.16E+4nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetNeuropeptides B/W receptor type 1(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50553731(CHEMBL4781597)
Affinity DataIC50: 2.50E+5nMAssay Description:Antagonist activity at human NPBWR1 assessed as inhibition of agonist-induced cAMP accumulation by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed